OraSure Technologies (OSUR) Misses Q4 EPS by 3c; Offers FY20 EPS/Revenue Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. WDC
2. DECK
3. RNG
4. BYD
5. FIX
6. SPOT
7. BE
8. KNSL
9. FCNCA
10. TSCO

Go back to OraSure Technologies (OSUR) Misses Q4 EPS by 3c; Offers FY20 EPS/Revenue Guidance Below Consensus

OraSure Announces 2019 Full Year and Fourth Quarter Financial Results

February 19, 2020 4:01 PM EST

BETHLEHEM, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced its financial results for the three months and year ended December 31, 2019.

Financial and Business Highlights

Net revenues for the fourth quarter of 2019 were $49.7 million, a 1% decrease from the fourth quarter of 2018. Net product revenues were $47.2 million, a 5% increase from the fourth quarter of 2018. Net product and service revenues in the... More